Intellia Therapeutics Inc buy SVB Leerink LLC
Start price
03.03.26
/
50%
€12.16
Target price
03.03.27
€24.79
Performance (%)
-7.24%
Price
28.04.26
€11.28
Summary
This prediction is currently active. With a performance of -7.24%, the BUY prediction by SVB_Leerink_LLC is trending in the wrong direction. This prediction currently runs until 03.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -13.629% | -13.629% |
| iShares Core DAX® | -0,37 % | 8,40 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % |
| iShares S&P 500 | 1,22 % | 10,49 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Leerink Partners from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat